Immediate Impact

49 standout
Sub-graph 1 of 24

Citing Papers

Lipid metabolic reprograming: the unsung hero in breast cancer progression and tumor microenvironment
2025 Standout
Harnessing machine learning to find synergistic combinations for FDA-approved cancer drugs
2024 Standout
2 intermediate papers

Works of Wenfei Ji being referenced

Combined Inhibition of ATR and WEE1 as a Novel Therapeutic Strategy in Triple-Negative Breast Cancer
2018
Therapeutic landscape in mutational triple negative breast cancer
2018

Author Peers

Author Last Decade Papers Cites
Wenfei Ji 260 194 101 176 9 402
Sara R. Martins‐Neves 284 225 116 172 9 453
Hehui Fang 224 180 85 180 10 386
Kårstein Måseide 299 198 70 177 10 448
Ramya Kumareswaran 265 184 102 211 9 433
Gorjan Hrustanovic 270 164 134 112 8 401
Frances K. Turrell 237 161 76 191 6 378
Susan D’Aloisio 258 139 127 86 7 402
Deepika Neelakantan 291 181 52 177 10 441
Mónica Fernández‐Cortés 273 147 49 152 9 393
Jenna Wheelhouse 208 212 69 91 9 368

All Works

Loading papers...

Rankless by CCL
2026